It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Microorganisms can be engineered to sustainably produce a variety of products including fuels, pharmaceuticals, materials, and food. However, highly engineered strains often result in low production yield, due to undesired effects such as metabolic burden and the toxicity of intermediates. Drawing inspiration from natural ecosystems, the construction of a synthetic community with division of labor can offer advantages for bioproduction. This approach involves dividing specific tasks among community members, thereby enhancing the functionality of each member. In this study, we identify six pairs out of fifteen composed of six auxotrophs of Yarrowia lipolytica that spontaneously form robust syntrophic and synergistic communities. We characterize the stability and growth dynamics of these communities. Furthermore, we validate the existence of syntrophic interactions between two yeast species, Y. lipolytica and Saccharomyces cerevisiae, and find a strain combination, Δtrp2 and Δtrp4, forming a stable syntrophic community between two species. Subsequently, we introduce a 3-hydroxypropionic acid (3-HP) biosynthesis pathway into the syntrophic community by dividing the pathway among different strains. Our results demonstrate improved production of 3-HP in both intra- and interspecies communities compared to monocultures. Our results show the stable formation of synthetic syntrophic communities, and their potential in improving bioproduction processes.
Microorganisms can be engineered to sustainably produce a variety of products including fuels, pharmaceuticals, materials, and food. This work reports the design and creation of syntrophic synthetic communities of single and multiple yeast species, which achieve improved bioproduction.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Imperial College London, Department of Bioengineering and Centre for Synthetic Biology, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, France (GRID:grid.462293.8) (ISNI:0000 0004 0522 0627)
2 Imperial College London, Department of Bioengineering and Centre for Synthetic Biology, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); The University of Queensland, Australian Institute of Bioengineering and Nanotechnology, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
3 Imperial College London, Department of Bioengineering and Centre for Synthetic Biology, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)